The Science publication represents a critical milestone in Mercks enlicitide development program Several key points distinguish this achievement VINP Vinci posts 49 percent Q4 2025 EPS miss with shares falling 063 percent in todays trade Is Moolec MLECW stock considered a safe play NNAVW NextNav market participants await quarterly earnings to gauge its core geolocation business growth momentum